Results 261 to 270 of about 1,599,561 (306)
Some of the next articles are maybe not open access.
Antiarrhythmic Drug Monitoring
Clinics in Laboratory Medicine, 1981The classification of antiarrhythmic agents by mechanism of action aids the clinician in selecting appropriate antiarrhythmic drug therapy. The pharmacokinetics, the side effects, and the interpretation of serum levels of quinidine, procainamide, disopyramide, lidocaine, and other agents are discussed.
J H, Howanitz, P J, Howanitz
openaire +2 more sources
Clinics in Laboratory Medicine, 1987
The principles, technique of measurement, and clinical significance of free drugs are reviewed. Albumin, alpha-1-acid glycoprotein, and lipoprotein are the main drug-binding proteins in blood. Variations of the concentrations of these proteins owing to disease would result in changes in the free drug levels.
S, Chan, B, Gerson
openaire +2 more sources
The principles, technique of measurement, and clinical significance of free drugs are reviewed. Albumin, alpha-1-acid glycoprotein, and lipoprotein are the main drug-binding proteins in blood. Variations of the concentrations of these proteins owing to disease would result in changes in the free drug levels.
S, Chan, B, Gerson
openaire +2 more sources
Drug level monitoring: cardiovascular drugs
Journal of Chromatography B: Biomedical Sciences and Applications, 1985Methods for the determination of cardiovascular drugs in blood and plasma are critically reviewed with emphasis on gas and liquid chromatographic techniques. The importance of the various procedures is discussed, in particular sample work-up where the conditions for isolation and derivatization of the compounds are decisive for the accuracy and ...
M, Ahnoff +4 more
openaire +2 more sources
Antineoplastic Drug Monitoring
Clinics in Laboratory Medicine, 1987The ability to monitor biologically significant levels of antineoplastic drugs in patients' plasma is rapidly expanding. The expanded application of therapeutic drug monitoring to the clinical practice of oncology will require a better understanding of the relationship between drug levels, toxicity, and therapeutic benefit in particular patient ...
openaire +2 more sources
Drug level monitoring of antiasthmatic drugs
Journal of Chromatography B: Biomedical Sciences and Applications, 1985In general assays pertaining to drug level monitoring (DLM) of antiasthmatic agents (except theophylline), published during the period 1978-1983, used mostly high-performance liquid chromatographic (HPLC) methodology (approximately 45%) with mass spectrometric (MS) based assays in second place (approximately 30%) followed by immunochemical techniques ...
N, Kucharczyk, F H, Segelman
openaire +2 more sources
Therapeutic Drug Monitoring of Antiarrhythmic Drugs
Clinical Pharmacokinetics, 2003Most antiarrhythmic drugs fulfil the formal requirements for rational use of therapeutic drug monitoring, as they show highly variable plasma concentration profiles at a given dose and a direct concentration-effect relationship. Therapeutic ranges for antiarrhythmic drugs are, however, often very poorly defined.
Gesche, Jürgens +2 more
openaire +2 more sources
16 Therapeutisches Drug Monitoring Drug Monitoring
2021Jan Dreher, Verena Lucas
openaire +1 more source
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly